🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Tirzepatide and PCOS — November 2025 Page 5

Tirzepatide and PCOS — November 2025

emma_london Sun, Mar 16, 2025 at 4:02 AM 34 replies 2,164 viewsPage 5 of 7
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Mar 27, 2025 at 5:41 PM#21
labquiet_amy said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Bookmarking. The distinction being drawn above is the one nobody else makes. Printing the relevant bit and taking it with me.

4 2CarlaRPh_TPA, steph_laguna, fiona_glasgow and 1 other
Reply Quote Save Share Report
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Mar 31, 2025 at 11:01 PM#22

Clinical perspective, offered as context rather than as advice. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

5 3alex_tucson, kevin_tulsa, Dr.PainCLE and 2 others
Reply Quote Save Share Report
matt_MKE
Member
312
1,345
Sep 2024
Milwaukee, WI
Apr 5, 2025 at 4:23 AM#23
hans_munich said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Second this.

6 4GraceAZ_72, carl_compliance, DanielChem_CHI and 3 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
alex_tucson
Member
567
2,345
May 2024
Tucson, AZ
Apr 9, 2025 at 9:48 AM#24
hans_munich said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Adding the part of the answer the thread has not reached. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

7 5ricardo_MIA, BrianDallas92, labquiet_amy and 4 others
Reply Quote Save Share Report
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Apr 13, 2025 at 3:15 PM#25

Adding the numbers, since they settle part of this. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

8 6labquiet_amy, emily_PDX, Dr.SleepRoch and 5 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register